Budetide Nebuliser Suspension 0.5 mg/2 ml is a glucocorticoid type of medication used to treat various medical conditions, including asthma, allergies, itching, rashes, and even certain types of cancer. It works by suppressing inflammation and reducing the body’s immune response. It is available in oral, inhaled, and topical forms, and is often prescribed as a part of a multi-drug treatment plan.
Budetide Nebuliser Suspension 0.5 mg/2 ml is primarily used to treat asthma and other related conditions. It is also sometimes used to treat allergies, ulcerative colitis, Crohn’s disease, and to reduce inflammation caused by certain types of cancer.
| Brand Name | Budetide |
|---|---|
| Type | Nebuliser Suspension |
| Weight | 0.5 mg/2 ml |
| Generic | Budesonide |
| Manufacturer | UniMed UniHealth |
| Available in | English বাংলা |
Budetide Nebuliser Suspension 0.5 mg/2 ml works by reducing the body’s inflammatory response. It is a type of glucocorticoid, which is a type of steroid that reduces inflammation by reducing production of certain chemical messengers which can trigger inflammation. Budetide Nebuliser Suspension 0.5 mg/2 ml also suppresses the immune system, which can help to reduce inflammation caused by an allergic response.
The specific time needed before Budetide Nebuliser Suspension 0.5 mg/2 ml starts to work depends on the form it is administered in and the condition being treated. In general, Budetide Nebuliser Suspension 0.5 mg/2 ml takes several days or even weeks to begin to take effect.
In most forms, Budetide Nebuliser Suspension 0.5 mg/2 ml is rapidly and completely absorbed when taken by mouth. It is well absorbed into the small intestine and is not broken down in the stomach. Inhaled Budetide Nebuliser Suspension 0.5 mg/2 ml has an absorption rate that varies greatly depending on the individual.
Budetide Nebuliser Suspension 0.5 mg/2 ml is eliminated from the body mostly by the kidneys through urinary excretion. Some of the medication is metabolized by the liver before excretion, and a small percentage is excreted unchanged in the feces.
The specific dosage of Budetide Nebuliser Suspension 0.5 mg/2 ml depends on the form being taken and the condition being treated. Oral forms are typically taken in divided doses between 0.8 and 9 mg daily, while inhaled forms are usually taken twice daily in doses between 0.5 and 4.5 mg. Topical forms are typically applied once or twice daily at 0.25 to 1 mg per application. It is important to closely follow the specific dosage and instructions provided by your doctor.
Budetide Nebuliser Suspension 0.5 mg/2 ml is available in oral, inhaled, and topical forms. Oral forms are taken by mouth, either with or without food, as prescribed by a doctor. Inhaled forms are usually administered through an inhaler device. Topical forms are applied directly to the skin.
Common side effects of Budetide Nebuliser Suspension 0.5 mg/2 ml may include nausea, vomiting, abdominal pain, fever, headache, nasal congestion, throat irritation, change in taste, coughing, and dizziness. More serious side effects may include difficulty breathing, chest pain, unusual muscle weakness, hives, rash, swelling of the face, lips, or tongue, confusion, blurred vision, or unusual tiredness.
Budetide Nebuliser Suspension 0.5 mg/2 ml is generally well tolerated and reported to have a low toxicity profile. Overdose may cause shaking, confusion, irregular heartbeat, sweating, and dizziness, which require immediate medical attention.
Patients with certain medical conditions, such as diabetes, glaucoma, cataracts, weakened immune system, seizure disorder, thyroid disorder, kidney or liver disease, or high blood pressure, should use Budetide Nebuliser Suspension 0.5 mg/2 ml cautiously. Budetide Nebuliser Suspension 0.5 mg/2 ml may cause changes in blood sugar levels, and patients with diabetes may need to adjust their insulin dose. It is also important to inform your doctor of any other medications you are taking, as Budetide Nebuliser Suspension 0.5 mg/2 ml may interact with certain drugs.
Budetide Nebuliser Suspension 0.5 mg/2 ml can interact with certain drugs, including corticosteroids, antifungals, antibiotics, and HIV medications. It can also interact with some supplements, such as St. John’s wort. It is important to inform your doctor of any other medications or supplements you are taking to avoid drug interactions.
Budetide Nebuliser Suspension 0.5 mg/2 ml may interact with certain medical conditions, such as diabetes, glaucoma, cataracts, weakened immune system, seizure disorder, thyroid disorder, kidney or liver disease, or high blood pressure. If you have any of these conditions, your doctor may need to adjust your dose of Budetide Nebuliser Suspension 0.5 mg/2 ml or monitor you more closely for side effects.
Budetide Nebuliser Suspension 0.5 mg/2 ml can interact with certain drugs, including corticosteroids, antifungals, antibiotics, and HIV medications. If you are taking any of these drugs, talk to your doctor before beginning Budetide Nebuliser Suspension 0.5 mg/2 ml, as your doctor may need to adjust your dosages.
Food interactions with Budetide Nebuliser Suspension 0.5 mg/2 ml are not known at this time. However, it is important to follow your doctor’s instructions regarding when to take your dose of Budetide Nebuliser Suspension 0.5 mg/2 ml.
Budetide Nebuliser Suspension 0.5 mg/2 ml is generally not recommended for use during pregnancy and lactation due to the risk of side effects such as birth defects. It is important to consult your doctor before taking Budetide Nebuliser Suspension 0.5 mg/2 ml if you are pregnant or breastfeeding.
Budetide Nebuliser Suspension 0.5 mg/2 ml is not typically recommended for use during lactation due to the risk of side effects such as birth defects. It is important to consult your doctor before taking Budetide Nebuliser Suspension 0.5 mg/2 ml if you are breastfeeding.
An acute overdose of Budetide Nebuliser Suspension 0.5 mg/2 ml can cause shaking, confusion, irregular heartbeat, sweating, and dizziness, which require immediate medical attention.
Patients who are pregnant, breastfeeding, or have an active infection should not take Budetide Nebuliser Suspension 0.5 mg/2 ml. Additionally, patients with severe kidney or liver impairment and those with a recent history of myocardial infarction should not take Budetide Nebuliser Suspension 0.5 mg/2 ml.
Budetide Nebuliser Suspension 0.5 mg/2 ml should be taken as prescribed by your doctor. Oral forms are usually taken in divided doses between 0.8 and 9 mg daily, inhaled forms are usually taken twice daily in doses between 0.5 and 4.5 mg, and topical forms are usually applied once or twice daily at 0.25 to 1 mg per application. It is important to closely follow the specific dosage and instructions provided by your doctor.
Budetide Nebuliser Suspension 0.5 mg/2 ml should be stored at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications out of the reach of children and pets.
Budetide Nebuliser Suspension 0.5 mg/2 ml has an average volume of distribution of 4-5 L/kg.
Budetide Nebuliser Suspension 0.5 mg/2 ml has an average elimination half-life of 2-4 hours.
Budetide Nebuliser Suspension 0.5 mg/2 ml has an average clearance rate of 7.5 mL/min/kg.
See in details version Budetide Nebuliser Suspension 0.5 mg/2 ml also Budetide Nebuliser Suspension 0.5 mg/2 ml in bangla
Dr. Md. Shahedur Rahman Sagor
Orthopedic (Bone, Joint, Arthritis, Trauma) Specialist & Surgeon